XT
TFFP

XTX Topco’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

XTX Topco’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-875
Closed -$7.66K – 2261
2023
Q3 		$7.66K Buy
+875
New +$8.2K ﹤0.01% 1437

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco's TFFP Position: Q4 2023 in Review

XTX Topco sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 875 shares — an estimated $7.66K sold.

XTX Topco first reported a position in TFFP in Q3 2023 and held it in 1 quarter. The position peaked at $7.66K in Q3 2023. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • XTX Topco reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • XTX Topco sold 875 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $7.66K.
  • XTX Topco first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • XTX Topco's TFF Pharmaceuticals, Inc. Common Stock position peaked at $7.66K in Q3 2023.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.